Altimmune Statistics
Total Valuation
Altimmune has a market cap or net worth of $365.43 million. The enterprise value is $236.38 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, before market open.
Earnings Date | May 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Altimmune has 77.01 million shares outstanding. The number of shares has increased by 33.35% in one year.
Current Share Class | 77.01M |
Shares Outstanding | 77.01M |
Shares Change (YoY) | +33.35% |
Shares Change (QoQ) | +0.25% |
Owned by Insiders (%) | 0.88% |
Owned by Institutions (%) | 52.97% |
Float | 76.34M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 18,329.25 |
Forward PS | n/a |
PB Ratio | 2.93 |
P/TBV Ratio | 2.97 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 11,818.75 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.11, with a Debt / Equity ratio of 0.01.
Current Ratio | 13.11 |
Quick Ratio | 12.90 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -11,463.56 |
Financial Efficiency
Return on equity (ROE) is -59.86% and return on invested capital (ROIC) is -40.31%.
Return on Equity (ROE) | -59.86% |
Return on Assets (ROA) | -36.85% |
Return on Invested Capital (ROIC) | -40.31% |
Return on Capital Employed (ROCE) | -80.08% |
Revenue Per Employee | $339 |
Profits Per Employee | -$1.61M |
Employee Count | 59 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.84% in the last 52 weeks. The beta is 0.89, so Altimmune's price volatility has been lower than the market average.
Beta (5Y) | 0.89 |
52-Week Price Change | -50.84% |
50-Day Moving Average | 6.17 |
200-Day Moving Average | 6.89 |
Relative Strength Index (RSI) | 35.31 |
Average Volume (20 Days) | 2,976,761 |
Short Selling Information
The latest short interest is 22.45 million, so 29.15% of the outstanding shares have been sold short.
Short Interest | 22.45M |
Short Previous Month | 21.67M |
Short % of Shares Out | 29.15% |
Short % of Float | 29.41% |
Short Ratio (days to cover) | 7.00 |
Income Statement
In the last 12 months, Altimmune had revenue of $20,000 and -$95.06 million in losses. Loss per share was -$1.34.
Revenue | 20,000 |
Gross Profit | -82.21M |
Operating Income | -103.17M |
Pretax Income | -101.35M |
Net Income | -95.06M |
EBITDA | -102.93M |
EBIT | -103.17M |
Loss Per Share | -$1.34 |
Full Income Statement Balance Sheet
The company has $131.89 million in cash and $1.68 million in debt, giving a net cash position of $130.21 million or $1.69 per share.
Cash & Cash Equivalents | 131.89M |
Total Debt | 1.68M |
Net Cash | 130.21M |
Net Cash Per Share | $1.69 |
Equity (Book Value) | 123.51M |
Book Value Per Share | 1.71 |
Working Capital | 126.79M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -79.85M |
Capital Expenditures | n/a |
Free Cash Flow | -79.85M |
FCF Per Share | -$1.04 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -515,860.00% |
Pretax Margin | -475,295.00% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Altimmune does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -33.35% |
Shareholder Yield | -33.35% |
Earnings Yield | -25.93% |
FCF Yield | -21.78% |
Dividend Details Analyst Forecast
The average price target for Altimmune is $21.00, which is 342.57% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $21.00 |
Price Target Difference | 342.57% |
Analyst Consensus | Strong Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | 625.89% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on September 14, 2018. It was a reverse split with a ratio of 0.0333333:1.
Last Split Date | Sep 14, 2018 |
Split Type | Reverse |
Split Ratio | 0.0333333:1 |
Scores
Altimmune has an Altman Z-Score of 12.93 and a Piotroski F-Score of 1.
Altman Z-Score | 12.93 |
Piotroski F-Score | 1 |